Böbrek kanserinde ARPC1A gen ekspresyonunun belirlenmesi

Renal cell carcinoma (RCC), in particular, is an important medical issue that is becoming more commonplace worldwide. Developing targeted therapeutics requires an understanding of the molecular pathways behind the disease's etiology. The ARPC1A gene is one of many genes linked to kidney cancer; however it has lately come to light due to its possible involvement in carcinogenesis and the advancement of the disease. Protein linked to actin the actin-related protein (ARP) family, which includes Subunit1A, is also known by the shortened form ARPC1A. This family of proteins is essential to many cellular functions, like the control of gene expression, intracellular transport, and cytoskeletal dynamics. The ARPC1A gene, located on chromosome 7q22.1, encodes the ARPC1A protein, a crucial component of the ARP2/3 complex. In order to enable cytoskeletal rearrangements that support cell motility, shape maintenance, and membrane dynamics—activities that include endocytosis, cell-cell adhesion, and cell motility—the ARP2/3 complex is a crucial regulator of actin filament nucleation and branching. This research analyzed gene expression rate samples in 11 effected cells and 11 control cells from the kidney of the same patient using quantitative reverse transcription PCR. In comparison to normal kidneys, the study found that kidney cancer tissue samples had 1.14 -fold higher ARPC1A gene expression; however, this increase is not statistically significant (p = 0.75). This abstract discusses the role of the ARPC1A gene in kidney cancer.